Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e473613f549ad747f3af840e73fac8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate |
2020-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff4a8652374fade38f351ec1c00dabac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4f10f6779d05101b52827ab3cf3a91a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8967b48a1c4feefb1dd59933daa78067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1637a5d671d76257124509a8dba737cd |
publicationDate |
2022-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2022323455-A1 |
titleOfInvention |
Fused heterocyclic derivatives as antiviral agents |
abstract |
The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection. |
priorityDate |
2019-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |